Jajodia Medichems Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 23-10-2024
- Paid Up Capital ₹ 6.50 M
as on 23-10-2024
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 73.95 M
as on 23-10-2024
- Satisfied Charges ₹ 40.00 M
as on 23-10-2024
- Revenue 36.42%
(FY 2023)
- Profit -68.12%
(FY 2023)
- Ebitda 540.83%
(FY 2023)
- Net Worth 5.09%
(FY 2023)
- Total Assets 4.64%
(FY 2023)
About Jajodia Medichems
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 6.50 M.
The company currently has active open charges totaling ₹7.40 Cr. The company has closed loans amounting to ₹4.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rajeev Jajodia and Rajesh Jajodia serve as directors at the Company.
- CIN/LLPIN
U24231WB1998PTC086515
- Company No.
086515
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Feb 1998
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jajodia Medichems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajeev Jajodia  | Whole-Time Director | 09-Feb-1998 | Current |
| Rajesh Jajodia | Whole-Time Director | 09-Feb-1998 | Current |
Financial Performance and Corporate Structure Insights of Jajodia Medichems.
Jajodia Medichems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 36.42% increase. The company also saw a substantial fall in profitability, with a 68.12% decrease in profit. The company's net worth moved up by a moderate rise of 5.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jajodia Medichems?
In 2023, Jajodia Medichems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Jajodia Projects Private Limited
Active 17 years 5 monthsRajeev Jajodia and Rajesh Jajodia are mutual person
Ankush Tradelink Private Limited
Active 14 years 6 monthsRajeev Jajodia and Rajesh Jajodia are mutual person
Award Vinimay Private Limited
Active 14 years 6 monthsRajeev Jajodia and Rajesh Jajodia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 15 Jun 2024 | ₹4.49 M | Open |
Others Creation Date: 31 Dec 2022 | ₹7.60 M | Open |
Others Creation Date: 11 Mar 2021 | ₹1.08 Cr | Open |
How Many Employees Work at Jajodia Medichems?
Unlock and access historical data on people associated with Jajodia Medichems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jajodia Medichems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jajodia Medichems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
